The global healthcare and life sciences industry continues to face dynamic challenges and changes, including heightened government scrutiny, pricing pressure, increased competition, scientific breakthroughs and technological innovation, along with customer and shareholder demands.

In order to address the needs of the industry, Shearman & Sterling is positioned to provide insightful and business-oriented advice on issues of governance, compliance, alternative financing, mergers and acquisitions, competition, strategic partnerships, IPOs, dispute resolutions, compensation and cyber security.

With extensive experience in both established and emerging markets, we understand your business and the evolving industry and provide tangible solutions aligned with your business priorities. Our lawyers in Asia, the Middle East, Europe and North America have helped companies of all sizes — from biotech start-ups to large multinational pharmaceutical companies.